FDA Approved Products
4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
NOVAFED
pseudoephedrine hydrochloride
LOE Approaching
Sanofi
ORAL · CAPSULE, EXTENDED RELEASE
1975
NDA30/100
NOVAMINE 11.4%
amino acids
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1978
NDA30/100
NOVAMINE 15%
amino acids
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1978
NDA30/100
NOVAMINE 15% SULFITE FREE IN PLASTIC CONTAINER
amino acids
LOE Approaching
Baxter
INJECTION · INJECTABLE
1993
NDA30/100
NOVAMINE 8.5%
amino acids
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1978
NDA30/100
NOVANTRONE
mitoxantrone hydrochloride
LOE Approaching
INJECTION · INJECTABLE
1987
NDA30/100
NOVANTRONE
mitoxantrone hydrochloride
LOE Approaching
INJECTION · INJECTABLE
2000
NDA30/100
NOVRAD
levopropoxyphene napsylate anhydrous
LOE Approaching
Eli Lilly and Company
ORAL · CAPSULE
1962
NDA30/100
NOXAFIL
posaconazole
LOE Approaching
Merck & Co.
ORAL · SUSPENSION
invasive aspergillosisolder+11
2006
SMNDA30/100
NOXAFIL
posaconazole
LOE Approaching
Merck & Co.
ORAL · SUSPENSION
2006
SMNDA30/100
NUBAIN
nalbuphine hydrochloride
LOE Approaching
Pfizer
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS · SOLUTION
1979
NDA30/100
NULYTELY
polyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride
LOE Approaching
R-Pharm US
ORAL · FOR SOLUTION
1991
NDA30/100
NULYTELY-FLAVORED
polyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride
LOE Approaching
R-Pharm US
ORAL · FOR SOLUTION
1991
NDA30/100
NUMORPHAN
oxymorphone hydrochloride
LOE Approaching
RECTAL · SUPPOSITORY
1960
NDA30/100
NUPRIN
ibuprofen
LOE Approaching
ORAL · TABLET
1984
SMNDA30/100
NUROMAX
doxacurium chloride
LOE Approaching
AbbVie
INJECTION · INJECTABLE
1991
NDA30/100
NUTRESTORE
l-glutamine
LOE Approaching
Emmaus Life Sciences
ORAL · FOR SOLUTION
2004
NDA30/100
NUTRILIPID 10%
soybean oil
LOE Approaching
B. Braun
INJECTION · INJECTABLE
1993
NDA30/100
NUTRILIPID 20%
soybean oil
LOE Approaching
B. Braun
INJECTION · INJECTABLE
1993
NDA30/100
NUVARING
etonogestrel and ethinyl estradiol
LOE Approaching
Merck & Co.
VAGINAL · RING
2001
NDA30/100
NUVIGIL
armodafinil
LOE Approaching
ORAL · TABLET
excessive sleepinesswakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA)+2
2007
NDA30/100
NYDRAZID
isoniazid
LOE Approaching
Novartis
INJECTION · INJECTABLE
1952
NDA30/100
OCL
polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate
LOE Approaching
Pfizer
ORAL · SOLUTION
1986
NDA30/100
OCTREOSCAN
indium in -111 pentetreotide
LOE Approaching
Curium Pharma
INJECTION · INJECTABLE
1994
PeptideNDA30/100